Navigation Links
Trillium secures additional financing on the strength of lead program and proprietary position around the CD200 immunoregulatory pathway
Date:9/18/2008

TORONTO, Sept. 18 /PRNewswire/ - Trillium Therapeutics Inc., a privately-held biopharmaceutical company specializing in the development of innovative therapies for the treatment of immune-mediated disorders, announced today that it has secured $12 million in new financing from its existing investors, VenGrowth Private Equity Partners, BDC Capital and Canadian Medical Discoveries Fund (CMDF).

"We are fortunate to have the continued support of some of Canada's premier venture capital investors, especially under these trying market conditions," commented Trillium CEO Dr. Niclas Stiernholm. "These funds will allow us to advance several programs into clinical development, elevating the company to a new level and opening up new strategic possibilities in 2009."

Trillium will use the majority of the proceeds to fund clinical trials of its lead product candidate, TTI-1612, a recombinant growth factor under parallel development for the prevention of necrotizing enterocolitis and the treatment of interstitial cystitis. TTI-1612 is on track to begin clinical testing by the end of 2008, and two additional trials are projected to commence in 2009. The company's two preclinical programs, a CD200-specific monoclonal antibody for the treatment of cancer, and a CD200Fc fusion protein for the treatment of autoimmune and inflammatory diseases, continue to hold promise and to generate strong scientific and commercial interest.

"Our continued support for Trillium is driven by the quality of the lead program TTI-1612, the strong patent position around the exciting new immunoregulatory target CD200, and management's proven ability to execute partnerships," added Dr. Luc Marengere, of VenGrowth Private Equity Partners, Trillium's largest investor.

About Trillium: Trillium Therapeutics Inc. is a private biopharmaceutical company specializing in innovative therapies of immune-mediated conditions, such as autoimmune and inflammatory disorders, as well as can
'/>"/>

SOURCE Trillium Therapeutics Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Althea Technologies Secures $12 M Credit Line to Continue Facility Growth and Expansion
2. Progenitor Cell Therapy Secures Industry Accreditation
3. BIOCOM Institute Secures Non-Profit Designation and Funding
4. Cara Therapeutics Secures $12.3 Million in Series C Extension Financing
5. OMTEC 2008 Boasts Record Attendance and Secures Premier Position as Must-attend for Orthopaedic Companies
6. Genta Secures Up to $40 Million Convertible Financing Facility to Fund Key Programs
7. Novasys Medical Secures $49.5 Million in Series D Financing to Expand Commercialization of Its Renessa(R) Treatment for Incontinence in Women
8. Veran Medical Technologies Secures $4.75M in First Institutional Funding
9. Northwest Secures US$4.0 Million in Debt Financing
10. D-Pharm Secures Funding From Israels Chief Scientists Office
11. Aerovance Secures $20 Million in Debt Financing

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/8/2009)... energy costs continue to soar, renewable sources ...n attractive replacement for gasoline is biofuel, ...earch ( www.genome.org ), scientists have analyze...croorganisms, uncovering genetic clues that will b...o implement production on a global scale. , Bioe...
(Date:11/6/2009)...Call/ -- BioSpecifics Technologies Corp. (Nasdaq: ...rst-in-class collagenase-based products, today ann... ended September 30, 2009. ,, "We were extreme...s Arthritis Advisory Committee unanimously recomme...M) for the treatment of Dupuytren,s disease, and w...
(Date:11/6/2009)...rstCall/ -- ,, 3Q09 Corporate Highlights: ...eting Authorization to Astellas Pharma Europe Ltd....ss activities Expanded management team to include...r, Commercial Operations Appointed Bradford S. Go...irman , Upcoming 2009 Milestones: ,, ...
(Date:11/6/2009)...head’s 2010 Personalized Medicine Partnershi...ary 22-24, 2010 in Philadelphia, has been announce...key issues in forming partnerships and engage the ... Minneapolis, MN (PRWEB) Novembe...0 Personalized Medicine Partnerships Conference , ...
Breaking Biology Technology:Genomes of biofuel yeasts reveal clues that could boost fuel ethanol production worldwide 2Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 2Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 3Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 4Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 5Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 6NeurogesX Reports Third Quarter 2009 Results 2NeurogesX Reports Third Quarter 2009 Results 3NeurogesX Reports Third Quarter 2009 Results 4NeurogesX Reports Third Quarter 2009 Results 5NeurogesX Reports Third Quarter 2009 Results 6NeurogesX Reports Third Quarter 2009 Results 7NeurogesX Reports Third Quarter 2009 Results 8NeurogesX Reports Third Quarter 2009 Results 9NeurogesX Reports Third Quarter 2009 Results 10Leaders in Biopharma and Molecular Diagnostics to Discuss Key Issues and Opportunities in Forming Partnerships at 2010 Personalized Medicine Partnerships Conference 2Leaders in Biopharma and Molecular Diagnostics to Discuss Key Issues and Opportunities in Forming Partnerships at 2010 Personalized Medicine Partnerships Conference 3
... DuPont and Athenix today announced they have e...sect control in corn and soybeans. , ... Park, NC (Vocus) January 15, 2009 -– DuPont...o a research collaboration to improve insect contr...ont business Pioneer Hi-Bred will use proprietar...
...Jan. 15 Regado Biosciences, Inc., announced today....A.C.C. to the position of Senior Vice President, ...icer, effective immediately. He will report to Da...hief Executive Officer. , , Dr. Mazzo stated, "St...velopment-stage and commercialized cardiovascular ...
...sic ethanol facility in Florida to serve as model ...ovides State support to project - , , CAMBRIDGE, ...NM ), a pioneer in the development of next-generat...lty enzymes, today announced plans to build its fi...n Highlands County, Florida. The Company has enter...
Other Biology Technology:DuPont and Athenix Collaborate to Advance Insect Control in Corn, Soybeans 2DuPont and Athenix Collaborate to Advance Insect Control in Corn, Soybeans 3Dr. Steven L. Zelenkofske Joins Regado Biosciences as Senior Vice President, Clinical and Medical Affairs and Chief Medical Officer 2Dr. Steven L. Zelenkofske Joins Regado Biosciences as Senior Vice President, Clinical and Medical Affairs and Chief Medical Officer 3Verenium Announces First Commercial Cellulosic Ethanol Project 2Verenium Announces First Commercial Cellulosic Ethanol Project 3Verenium Announces First Commercial Cellulosic Ethanol Project 4Verenium Announces First Commercial Cellulosic Ethanol Project 5Verenium Announces First Commercial Cellulosic Ethanol Project 6
(Date:11/6/2009)...l Center and the Chinese Academy of Sciences (CAS)... on Taste and Smell Research. Organized by Monell ... the first international meeting on taste and smel...cutive Officer, American Association for the Advan...ce magazine, will open the meeting with a plenary ...
(Date:11/4/2009)... United States Using Less Water Today , The U...years ago, despite a 30 percent population increas...o alternative cooling methods at power plants and ...e latest USGS water use report, nearly half of all...hermoelectric power plants. Irrigation accounts fo...
(Date:11/4/2009)...ceived more than $10 million in research grants fr...imulus program, bringing thetotal amount of stimul...on. Thirty-three projects achieved stimulus fundi.... , "The university has thoughtfully undertaken ...y excellence to federal agency priorities. Throug...
Breaking Biology News(10 mins):Monell Center joins with CAS to host Beijing meeting on taste and smell research 2USGS science picks 2USGS science picks 3USGS science picks 4USGS science picks 5USGS science picks 6USGS science picks 7OU achieves $10 million in stimulus grants for 33 projects on the Norman campus 2OU achieves $10 million in stimulus grants for 33 projects on the Norman campus 3CVS Caremark Celebrates Outstanding Pharmacy Care to Patients During American Pharmacists Month in October 5133 1CVS Caremark Celebrates Outstanding Pharmacy Care to Patients During American Pharmacists Month in October 5133 2Spatial Integrated Systems Inc Files Patent Application 10210 1Spatial Integrated Systems Inc Files Patent Application 10210 2Lung cancer risk increases with expression of specific genes 58648 1Lung cancer risk increases with expression of specific genes 58648 2
...uper-intense radiation delivered by a robotic arm ... 3-4 months after treatment, medical physicist Cih...h Medical Center will report in early August at th...of Physicists in Medicine in Orlando. Although it...rm effectiveness, Ozhasoglu and his colleagues fin...
...accines made with bacteria killed by gamma irradia...hemical inactivation, may be more effective, say r...Allergy and Infectious Diseases (NIAID), part of t...ade from gamma-irradiated bacteria also may not ne... refrigerating vaccines is impractical or impossib...
...hen used indoors under certain conditions, many co...xic pollutants at levels that may lead to health r...he University of California, Berkeley, and Lawrenc...to some of the pollutants ?and to the secondary po... ozone ?may exceed regulatory guidelines when a la...
Other Biology News:Radiation-armed robot rapidly destroys human lung tumors 2Radiation-killed bacteria vaccine induces broad immune response in mice 2Radiation-killed bacteria vaccine induces broad immune response in mice 3Many cleaners, air fresheners may pose health risks when used indoors 2Many cleaners, air fresheners may pose health risks when used indoors 3Many cleaners, air fresheners may pose health risks when used indoors 4Many cleaners, air fresheners may pose health risks when used indoors 5Many cleaners, air fresheners may pose health risks when used indoors 6
... belong to the transforming growth factor- (TGF-) ... of extra-cellular growth factors which control ma...nd tumor formation (1). Other members incude TGF-s...ion factors, AMH/MIS (Anti-Mullerian Hormone/Mulle...
...ng in just seconds , No need for glass rods and ...rm spreading and more colonies, Two choices of re... spreading 100 plates or single-use tubes for 50 p...on multiple plates simultaneously ,EZ-Spread Pla...
Silencer siRNA Starter Kit from Ambion
... environment, Pipette Tracker Pro is the only pipe...c pipette calibration and record keeping within a ...requirements. Pipette Tracker Pro is a secure solu... support for Oracle and SQL Server databases, meth...
Biology Products: